skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 147,480  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries
Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries
Material Type:
Article 		Add to My Research

Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries

Bulletin of the World Health Organization, 2014-09, Vol.92 (9), p.641-655 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright World Health Organization Sep 2014 ;(c) 2014 The authors; licensee World Health Organization. 2014 ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.13.129247 ;PMID: 25378755 ;CODEN: BWHOA6

Full text available

Citations Cited by
2
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Material Type:
Article 		Add to My Research

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1406-1417 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60734-X ;PMID: 22938757 ;CODEN: LANCAO

Full text available

Citations Cited by
3
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 4, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61719-5 ;PMID: 24094768 ;CODEN: LANCAO

Full text available

Citations Cited by
4
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Article 		Add to My Research

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.42.8201 ;PMID: 22949147

Full text available

Citations Cited by
5
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Article 		Add to My Research

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.48.4410 ;PMID: 23980084

Full text available

Citations Cited by
6
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
Material Type:
Article 		Add to My Research

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

Journal of clinical oncology, 2013-08, Vol.31 (24), p.3004-3011 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.42.3749 ;PMID: 23835708

Full text available

Citations Cited by
7
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Article 		Add to My Research

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61134-9 ;PMID: 23158522 ;CODEN: LANCAO

Full text available

Citations Cited by
8
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Material Type:
Article 		Add to My Research

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1252-1260 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.28.0982 ;PMID: 21383283

Full text available

Citations Cited by
9
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma
Material Type:
Article 		Add to My Research

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

European urology, 2011-04, Vol.59 (4), p.543 [Peer Reviewed Journal]

Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved. ;EISSN: 1873-7560 ;DOI: 10.1016/j.eururo.2010.12.013 ;PMID: 21186077

Digital Resources/Online E-Resources

Citations Cited by
10
Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies
Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies
Material Type:
Article 		Add to My Research

Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies

International journal of cancer, 2012-09, Vol.131 (5), p.1210-1219 [Peer Reviewed Journal]

Copyright © 2011 UICC. ;ISSN: 0020-7136 ;ISSN: 1097-0215 ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.27339 ;PMID: 22052329

Digital Resources/Online E-Resources

Citations Cited by
11
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Material Type:
Article 		Add to My Research

Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

American journal of epidemiology, 2013-09, Vol.178 (5), p.679-690 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Oxford Publishing Limited(England) Sep 1, 2013 ;The Author 2013. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2013 ;ISSN: 0002-9262 ;EISSN: 1476-6256 ;DOI: 10.1093/aje/kwt029 ;PMID: 23817919 ;CODEN: AJEPAS

Full text available

Citations Cited by
12
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Material Type:
Article 		Add to My Research

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

Clinical microbiology and infection, 2011-12, Vol.17 (12), p.1859-1867 [Peer Reviewed Journal]

2011 European Society of Clinical Infectious Diseases ;2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases ;2015 INIST-CNRS ;2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases. ;ISSN: 1198-743X ;EISSN: 1469-0691 ;DOI: 10.1111/j.1469-0691.2010.03456.x ;PMID: 21199154

Digital Resources/Online E-Resources

Citations Cited by
13
Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
Material Type:
Article 		Add to My Research

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1547-1553 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.25.4706 ;PMID: 20159816

Full text available

Citations Cited by
14
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Material Type:
Article 		Add to My Research

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Blood, 2011-10, Vol.118 (17), p.4567-4576 [Peer Reviewed Journal]

2011 American Society of Hematology ;2015 INIST-CNRS ;2011 by The American Society of Hematology 2011 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-05-355594 ;PMID: 21865346

Full text available

Citations Cited by
15
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Material Type:
Article 		Add to My Research

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 2012 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(11)70290-0 ;PMID: 22018760 ;CODEN: LANCAO

Full text available

Citations Cited by
16
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Material Type:
Article 		Add to My Research

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Blood, 2012-04, Vol.119 (15), p.3403-3412 [Peer Reviewed Journal]

2012 American Society of Hematology ;2015 INIST-CNRS ;2012 by The American Society of Hematology 2012 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-11-390120 ;PMID: 22371878

Full text available

Citations Cited by
17
Relevance of body mass index and bioelectrical impedance analysis vs. deuterium dilution technique to assess excess of fat among young adults
Relevance of body mass index and bioelectrical impedance analysis vs. deuterium dilution technique to assess excess of fat among young adults
Material Type:
Article 		Add to My Research

Relevance of body mass index and bioelectrical impedance analysis vs. deuterium dilution technique to assess excess of fat among young adults

Isotopes in environmental and health studies, 2021-05, Vol.57 (2), p.193 [Peer Reviewed Journal]

EISSN: 1477-2639 ;DOI: 10.1080/10256016.2020.1860958 ;PMID: 33372545

Digital Resources/Online E-Resources

Citations Cited by
18
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Material Type:
Article 		Add to My Research

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

International journal of cancer, 2013-02, Vol.132 (4), p.854 [Peer Reviewed Journal]

Copyright © 2012 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.27713 ;PMID: 22752992

Digital Resources/Online E-Resources

Citations Cited by
19
Clinical-neurophysiological correlations in patients with depressive-delusional conditions
Clinical-neurophysiological correlations in patients with depressive-delusional conditions
Material Type:
Article 		Add to My Research

Clinical-neurophysiological correlations in patients with depressive-delusional conditions

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Vol.121 (2), p.46 [Peer Reviewed Journal]

ISSN: 1997-7298 ;DOI: 10.17116/jnevro202112102146 ;PMID: 33728850

Digital Resources/Online E-Resources

Citations Cited by
20
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9664), p.641-648 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Feb 21-Feb 27, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60402-5 ;PMID: 19231632 ;CODEN: LANCAO

Full text available

Citations Cited by

Results 1 - 20 of 147,480  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1965  (171)
  2. 1965 To 1978  (49,519)
  3. 1979 To 1992  (56,545)
  4. 1993 To 2007  (25,430)
  5. After 2007  (16,658)
  6. More options open sub menu

Subject 

  1. Humans  (145,788)
  2. Adult  (145,206)
  3. Male  (98,190)
  4. Middle Aged  (95,350)
  5. Female  (93,298)
  6. Adolescent  (48,492)
  7. Aged  (43,581)
  8. Child  (16,824)
  9. Time Factors  (12,629)
  10. Chronic Disease  (10,922)
  11. Child, Preschool  (7,320)
  12. Diagnosis, Differential  (7,130)
  13. Science & Technology  (6,973)
  14. Follow-Up Studies  (6,970)
  15. Life Sciences & Biomedicine  (6,965)
  16. Acute Disease  (6,255)
  17. Treatment Outcome  (6,001)
  18. Age Factors  (5,196)
  19. Pregnancy  (5,166)
  20. Young Adult  (4,316)
  21. More options open sub menu

Language 

  1. English  (3,788)
  2. Japanese  (137)
  3. German  (18)
  4. Serbian  (14)
  5. Ukrainian  (11)
  6. French  (8)
  7. Arabic  (6)
  8. Spanish  (6)
  9. Lithuanian  (5)
  10. Azerbaijani  (5)
  11. Turkish  (4)
  12. Bulgarian  (4)
  13. Georgian  (2)
  14. Hungarian  (1)
  15. Somali  (1)
  16. Portuguese  (1)
  17. Lao  (1)
  18. Polish  (1)
  19. Chinese  (1)
  20. More options open sub menu

on this subject:

  1. Humans
  2. Adult
  3. Male
  4. Middle Aged
  5. Female
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait